Skip to content

Clinical trials

Phase 2 Hepatitis B, Chronic trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 2 Country / region: Taiwan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20152
20161
20171
20181
20191
20207
20214
20223
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting3
Terminated2
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences6
Janssen Research & Development, LLC4
GlaxoSmithKline3
Arbutus Biopharma Corporation2
Hoffmann-La Roche2
A2 Healthcare Taiwan Corporation1
Aligos Therapeutics1
Assembly Biosciences1
AusperBio Therapeutics Inc.1
Barinthus Biotherapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic26
Hepatitis B11
Hepatitis5
Carcinoma, Hepatocellular2
Liver Diseases2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.